Healthcare provider profile · identity verified

William Brown

Internal Medicine · BIRMINGHAM, AL · NPI 1558781088

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	566	194
Gabapentin	Gabapentin	340	95
Amlodipine Besylate	Amlodipine Besylate	322	117
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	230	52
Omeprazole	Omeprazole	178	61
Metformin Hcl	Metformin Hcl	177	57
Losartan Potassium	Losartan Potassium	173	61
Lisinopril	Lisinopril	171	66
Eliquis	Apixaban	160	37
Levothyroxine Sodium	Levothyroxine Sodium	159	52
Ozempic	Semaglutide	144	35
Metoprolol Succinate	Metoprolol Succinate	140	49
Trazodone Hcl	Trazodone Hcl	140	47
Pantoprazole Sodium	Pantoprazole Sodium	135	53
Chlorthalidone	Chlorthalidone	124	37
Zolpidem Tartrate	Zolpidem Tartrate	117	22
Tramadol Hcl	Tramadol Hcl	112	25
Tamsulosin Hcl	Tamsulosin Hcl	111	36
Hydrochlorothiazide	Hydrochlorothiazide	110	43
Rosuvastatin Calcium	Rosuvastatin Calcium	100	39
Allopurinol	Allopurinol	98	35
Pregabalin	Pregabalin	94	20
Carvedilol	Carvedilol	93	36
Duloxetine Hcl	Duloxetine Hcl	91	25
Alprazolam	Alprazolam	90	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	84	19
Pravastatin Sodium	Pravastatin Sodium	84	31
Metoprolol Tartrate	Metoprolol Tartrate	78	24
Sertraline Hcl	Sertraline Hcl	78	23
Jardiance	Empagliflozin	77	23
Olmesartan Medoxomil	Olmesartan Medoxomil	77	34
Metformin Hcl Er	Metformin Hcl	75	33
Potassium Chloride	Potassium Chloride	73	27
Albuterol Sulfate Hfa	Albuterol Sulfate	72	36
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	66	25
Clonazepam	Clonazepam	66	22
Fluticasone Propionate	Fluticasone Propionate	66	29
Furosemide	Furosemide	65	31
Meloxicam	Meloxicam	65	26
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	61	23
Esomeprazole Magnesium	Esomeprazole Magnesium	60	26
Famotidine	Famotidine	55	15
Spironolactone	Spironolactone	54	21
Methocarbamol	Methocarbamol	53	17
Oxycodone Hcl	Oxycodone Hcl	52	15
Citalopram Hbr	Citalopram Hydrobromide	51	22
Montelukast Sodium	Montelukast Sodium	51	18
Fluoxetine Hcl	Fluoxetine Hcl	48	15
Mounjaro	Tirzepatide	47	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	18
Tizanidine Hcl	Tizanidine Hcl	45	17
Bupropion Xl	Bupropion Hcl	44	14
Finasteride	Finasteride	44	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	17
Levetiracetam	Levetiracetam	41	suppressed
Lorazepam	Lorazepam	39	14
Simvastatin	Simvastatin	39	18
Farxiga	Dapagliflozin Propanediol	38	suppressed
Ibuprofen	Ibuprofen	38	16
Alendronate Sodium	Alendronate Sodium	36	12
Trulicity	Dulaglutide	36	11
Valacyclovir	Valacyclovir Hcl	36	11
Azelastine Hcl	Azelastine Hcl	35	suppressed
Baclofen	Baclofen	35	14
Colchicine	Colchicine	35	16
Januvia	Sitagliptin Phosphate	35	suppressed
Clopidogrel	Clopidogrel Bisulfate	34	15
Escitalopram Oxalate	Escitalopram Oxalate	34	16
Hydralazine Hcl	Hydralazine Hcl	34	13
Donepezil Hcl	Donepezil Hcl	33	suppressed
Mirtazapine	Mirtazapine	33	15
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	33	15
Ondansetron Hcl	Ondansetron Hcl	33	17
Prednisone	Prednisone	33	14
Ezetimibe	Ezetimibe	32	12
Acetaminophen-Codeine	Acetaminophen With Codeine	31	suppressed
Atenolol	Atenolol	31	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	11
Amitriptyline Hcl	Amitriptyline Hcl	30	12
Bupropion Hcl Sr	Bupropion Hcl	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Glimepiride	Glimepiride	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Celecoxib	Celecoxib	28	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	21
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Azithromycin	Azithromycin	26	26
Novolog Flexpen	Insulin Aspart	26	11
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	12
Lantus	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	18
Buspirone Hcl	Buspirone Hcl	22	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	22	suppressed
Fluconazole	Fluconazole	22	18
Propranolol Hcl	Propranolol Hcl	22	suppressed
Entresto	Sacubitril/Valsartan	21	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Topiramate	Topiramate	21	suppressed
Diazepam	Diazepam	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	13
Xarelto	Rivaroxaban	20	suppressed
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Benazepril Hcl	Benazepril Hcl	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Nystatin	Nystatin	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Admelog Solostar	Insulin Lispro	11	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Estradiol	Estradiol	11	suppressed
Naproxen	Naproxen	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	suppressed
Temazepam	Temazepam	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error